BioCentury | Apr 19, 2018
Translation in Brief

One-two punch for West Nile

...no approved therapies or vaccines for West Nile virus (WNV). At least two companies -- Hawaii Biotech Inc....
BioCentury | Feb 15, 2016
Politics, Policy & Law

Nature won't wait

...childbearing age are certain to receive a successful vaccine. Elliot Parks, president and CEO of Hawaii Biotech Inc....
...BIO), Washington, D.C. European Medicines Agency (EMA), London, U.K. GlaxoSmithKline plc (LSE:GSK; NYSE:GSK), London, U.K. Hawaii Biotech Inc....
...Inc. (OTCQB:GOVX) / University of Georgia Modified vaccinia virus Ankara - virus-like particle (MVA-VLP) vaccine Hawaii Biotech Inc....
BioCentury | Jun 15, 2015
Company News

Soligenix, Hawaii Bio, University of Hawaii deal

...from the University of Colorado (see BioCentury, Jan. 31, 2011). Soligenix Inc. (OTCBB:SNGX), Princeton, N.J. Hawaii Biotech Inc....
BioCentury | Feb 10, 2014
Company News

Hawaii Bio, NIH infectious news

...factor inhibitors. The NIAID award has a first-year period of performance valued at $1.1 million. Hawaii Biotech Inc....
BioCentury | Apr 22, 2013
Company News

Hawaii Bio, Merck & Co Inc. deal

...Dengue fever vaccine program. The companies declined to disclose details (see BioCentury, Aug. 16, 2010). Hawaii Biotech Inc....
BioCentury | Nov 7, 2011
Company News

Hawaii Bio, Merck deal

...Merck acquired Hawaii Biotech's Dengue fever vaccine program last year (see BioCentury, Aug. 16, 2010). Hawaii Biotech Inc....
BioCentury | Jun 27, 2011
Company News

Hawaii Bio infectious news

...has completed Phase I testing. The company's Tick-Borne Encephalopathy Vaccine is currently in preclinical testing. Hawaii Biotech Inc....
BioCentury | Aug 16, 2010
Company News

Hawaii Bio, Merck deal

...trial. Hawaii Biotech filed for Chapter 11 bankruptcy in December. Further details were not disclosed. Hawaii Biotech Inc....
BioCentury | Aug 31, 2009
Clinical News

Dengue fever vaccine: Phase I started

...HBV-001 D1 with Alhydrogel adjuvant given once every 4 weeks in 16 healthy adult volunteers. Hawaii Biotech Inc....
BioCentury | Apr 20, 2009
Company News

Acuvax, RESprotect deal

...vaccine for West Nile virus in Phase I testing. The vaccine is being developed by Hawaii Biotech Inc....
Items per page:
1 - 10 of 23
BioCentury | Apr 19, 2018
Translation in Brief

One-two punch for West Nile

...no approved therapies or vaccines for West Nile virus (WNV). At least two companies -- Hawaii Biotech Inc....
BioCentury | Feb 15, 2016
Politics, Policy & Law

Nature won't wait

...childbearing age are certain to receive a successful vaccine. Elliot Parks, president and CEO of Hawaii Biotech Inc....
...BIO), Washington, D.C. European Medicines Agency (EMA), London, U.K. GlaxoSmithKline plc (LSE:GSK; NYSE:GSK), London, U.K. Hawaii Biotech Inc....
...Inc. (OTCQB:GOVX) / University of Georgia Modified vaccinia virus Ankara - virus-like particle (MVA-VLP) vaccine Hawaii Biotech Inc....
BioCentury | Jun 15, 2015
Company News

Soligenix, Hawaii Bio, University of Hawaii deal

...from the University of Colorado (see BioCentury, Jan. 31, 2011). Soligenix Inc. (OTCBB:SNGX), Princeton, N.J. Hawaii Biotech Inc....
BioCentury | Feb 10, 2014
Company News

Hawaii Bio, NIH infectious news

...factor inhibitors. The NIAID award has a first-year period of performance valued at $1.1 million. Hawaii Biotech Inc....
BioCentury | Apr 22, 2013
Company News

Hawaii Bio, Merck & Co Inc. deal

...Dengue fever vaccine program. The companies declined to disclose details (see BioCentury, Aug. 16, 2010). Hawaii Biotech Inc....
BioCentury | Nov 7, 2011
Company News

Hawaii Bio, Merck deal

...Merck acquired Hawaii Biotech's Dengue fever vaccine program last year (see BioCentury, Aug. 16, 2010). Hawaii Biotech Inc....
BioCentury | Jun 27, 2011
Company News

Hawaii Bio infectious news

...has completed Phase I testing. The company's Tick-Borne Encephalopathy Vaccine is currently in preclinical testing. Hawaii Biotech Inc....
BioCentury | Aug 16, 2010
Company News

Hawaii Bio, Merck deal

...trial. Hawaii Biotech filed for Chapter 11 bankruptcy in December. Further details were not disclosed. Hawaii Biotech Inc....
BioCentury | Aug 31, 2009
Clinical News

Dengue fever vaccine: Phase I started

...HBV-001 D1 with Alhydrogel adjuvant given once every 4 weeks in 16 healthy adult volunteers. Hawaii Biotech Inc....
BioCentury | Apr 20, 2009
Company News

Acuvax, RESprotect deal

...vaccine for West Nile virus in Phase I testing. The vaccine is being developed by Hawaii Biotech Inc....
Items per page:
1 - 10 of 23